Castleman's disease other diagnostic studies

Castleman's disease Microchapters
Home
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Castleman's disease from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Castleman's disease other diagnostic studies On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Castleman's disease other diagnostic studies All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Castleman's disease other diagnostic studies
CDC on Castleman's disease other diagnostic studies
Castleman's disease other diagnostic studies in the news
Blogs on Castleman's disease other diagnostic studies
Directions to Hospitals Treating Castleman's disease
Risk calculators and risk factors for Castleman's disease other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]

Biopsy

• Lymph node biopsy is used as a differentiating tool in the diagnosis of Castleman's disease. It is used to differentiate Castleman's from lymphoma.
• Variants of Castleman's disease can also be differentiated using biopsy.

Micrograph of Castleman's disease, hyaline vascular variant, exhibiting the characteristically expanded mantle zone and a radially penetrating sclerotic blood vessel ("lollipop" sign). H&E stain.	Intermediate magnification micrograph of Castleman disease showing the characteristic expansion of the mantle zone, known as "onion skinning". H&E stain.